Stanford Cancer Institute
Translating Stanford discoveries into individualized cancer care
Every day, people living with cancer come to Stanford for help, hope and healing.
.jpeg)
The Future of Cancer
The SCI is focused on pushing the limits of what we can do and what we know. The only way to really advance our knowledge is to push forward in laboratories, keep thinking about novel approaches, novel mechanisms. We cannot stand still!
National Cancer Institute Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
Designation as a Comprehensive Cancer Center signifies that the Stanford Cancer Institute maintains the highest level of scientific rigor, institutional support and coordination for the complete range of cancer-related research, including basic, translational, clinical and population-based science. The designation is recognition of the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The Institute’s mission is to support and coordinate the wide range of cancer-related activities — in basic, translational, clinical and population-based science — occurring at Stanford University, Stanford Health Care and Lucile Packard Children’s Hospital Stanford. Its over 450 members include scientists and physicians from a wide range of disciplines, all collaborating to translate research advances into improved cancer treatments.
-
Removing tumor from a tricky part of brain, surgeon gives teen his life back
After years of practicing surgery techniques in a part of the brain known as a “no man’s land,” Juan Fernandez-Miranda was able to remove a complex pituitary gland tumor from a Lebanese teenager.
-
Robot provides Stanford Health Care – ValleyCare patient with shorter, less invasive surgery
Stanford Health Care – ValleyCare physician performs surgery on a cancer patient with the help of a da Vinci robotic system. The technology eases patients’ recovery and offers surgeons a clear view of the procedure.
-
Study predicts who may benefit from CAR-T cell therapy for blood cancers
CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.
Cancer Clinical Trials
Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.